Earlier sustained virologic response end points for regulatory approval and dose selection of hepatitis C therapies (Q86309140)
Jump to navigation
Jump to search
scientific article published on 05 March 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Earlier sustained virologic response end points for regulatory approval and dose selection of hepatitis C therapies |
scientific article published on 05 March 2013 |
Statements
Earlier sustained virologic response end points for regulatory approval and dose selection of hepatitis C therapies (English)
Jianmeng Chen
Jeffry Florian
Wendy Carter
Russell D Fleischer
Thomas S Hammerstrom
Pravin R Jadhav
Wen Zeng
Jeffrey Murray
Debra Birnkrant
5 March 2013